Leadership & History

An active leader in the pharmaceutical marketplace for more than 20 years, Stuart co-founded QuVa Pharma in 2015 with long-standing business partner Peter Jenkins. Under their leadership, QuVa has experienced consistent year-over-year growth and is still rapidly expanding.

Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Stuart served as President and COO from 2007-2010 and CEO from 2011-2014. He was instrumental in establishing JHP as a leading injectable pharmaceutical company in the United States before selling the business in 2014.

Previously, Stuart was President of Mayne Pharma Americas, a unit of Mayne that was focused on the manufacture, development, and sale of generic injectable pharmaceuticals, primarily into the hospital market. He led the Americas activity through a period of significant growth and established Mayne Pharma USA as a stand-alone business, ultimately building the division into one of the leading generic oncology providers in the United States.

Specializing in global corporate development and finance, Peter has focused on the pharmaceutical marketplace for the last 20+ years of his storied career. He co-founded QuVa Pharma in 2015 with long-standing business partner Stuart Hinchen. Under their leadership, the firm has experienced consistent year-over-year growth and is still rapidly expanding.

Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Peter served as CEO from 2007-2010 and CDO from 2011-2014, increasing JHP’s portfolio through development and manufacturing partnerships. He helped establish JHP as a leading injectable pharmaceutical company before selling the company in 2014.

Previously, Peter served as CDO of Mayne Group and a Director of Mayne Pharma, where he was instrumental in the acquisition of the largest sterile compounding business in the UK and the acquisition and construction of several FDA-approved pharmaceutical manufacturing facilities. During his tenure, he managed business and product development groups in the U.S., Europe, India, and Australia, and was responsible for all corporate development activities.

Ryan Sullivan directs QuVa’s legal and healthcare compliance efforts and serves as legal advisor and secretary to the board of directors. Ryan has over 14 years of experience in the pharmaceutical space. Before joining QuVa, Ryan served as the General Counsel and Secretary of Intercept Pharmaceuticals, where he was responsible for all corporate governance, SEC reporting, litigation, intellectual property, and other legal matters.  Prior to that, he served as General Counsel and Secretary of Anacor Pharmaceuticals, whereas the company’s first in-house attorney, he was responsible for all legal matters and establishing scalable legal and healthcare compliance functions. Ryan also served in several positions of increasing responsibility at Warner Chilcott and practiced in the New York corporate law group of Cahill Gordon & Reindel.

Ryan received his Bachelor of Science from Cornell University and his J.D. from Cornell Law School.

Mike has been in the healthcare field for the last 22 years and has a diverse and extensive commercial background in Sales and Marketing. He joined QuVa in 2017 from having previously led Sales and Marketing organizations at pharmaceutical companies Pfizer, Alexion, and Mylan. He has deep experience across generic, branded, and biosimilar pharmaceutical markets and customers that span Hospital & IDN, Clinic, Specialty Pharmacy, Wholesaler & Distributor, Patient and Payer.

Mike is responsible for leading QuVa Pharma’s corporate, product, and services marketing, as well as internal and external corporate communications.

Scott has extensive experience in the healthcare industry, including Solta Medical and Bausch Health Companies as well as broad and extensive portfolio management positions with Citadel, Plural Investments and Credit Suisse.  Scott joined QuVa in March of 2023 and as an integral member of the executive management team, Scott drives priorities, resources, and timelines to produce measurable performance by delivering to financial goals aligned with QuVa’s company vision, strategy, and values.

Having more than 30 years of pharmaceutical experience, David is knowledgeable in cGMPs and specializes in parenteral drug manufacturing, specifically with Quality and Research & Development. Prior to joining QuVa Pharma, David held leadership roles in Quality and Research & Development with Par, JHP Pharmaceuticals, and Hospira supporting the manufacturing of sterile injectables. David has additional leadership experience in quality roles with Johnson & Johnson, Pfizer, Pharmacia, and Upjohn supporting the pharmaceutical manufacturing of API, OTC, and prescription drugs. David has a strong background in operational excellence, driving continuous improvement in processes and people through coaching and training.

Dr. Eschenbacher brings over 20 years of health care pharmacy experience and is responsible for all of QuVa’s pharmacy and clinical operations. She also oversees compliance activities including DEA and State Board of Pharmacy responsibilities. Previously, she has held roles as the Chief Pharmacy Officer for Ascension, served as Assistant Director of Pharmacy at WakeMed Health & Hospitals, and the Medication Safety Officer for Duke University Hospital.  

Dr. Eschenbacher holds a PharmD from the University of Texas as well as an MBA from The Fuqua School of Business at Duke University. She has been awarded the National Distinguished Service Award by the American Society of Health-System Pharmacists (ASHP) and is also a fellow of ASHP.

Steve has over 24 years of experience in the pharmaceutical industry, predominantly in Regulatory and Scientific Affairs, with a strong understanding of global development and filing requirements focusing on generics and specialty pharmaceuticals. Steve joins QuVa with extensive expertise in the pharmaceutical business – including product selection, product development, intellectual property, business development, finance, sales & marketing, quality, and manufacturing. Steve brings a high proficiency in communicating strategic and tactical information to all levels and negotiating successful outcomes with business partners and Health Authorities.

Steve earned his Bachelor of Science, Chemistry and Microbiology from the University of South Australia, Australia, and an MBA from the University of Adelaide, Australia.

Varsha has 25 years of experience in Hospital Management, Home Infusion, Regulatory Affairs, and Clinical Research. Her expertise with inpatient medication management and drug therapy combined with manufacturing and compounding provide clinical leadership to the QuVa team. She is a biologist, chemist, and pharmacist with a PharmD and a PhD and holds multiple Board Certifications.

Varsha is an active member of ASHP and has served in the House of Delegates. Her patient care experience includes Memorial Hermann, Healix, Houston Methodist, and CHI St. Luke’s, and her research experience includes Baylor College of Medicine and UCSF.

Having more than 21 years in the sterile compounding business and 29 years in pharmacy practice, Travis leads QuVa Pharma’s Clinical Services and Pharmacists-in-Charge (PIC) teams, who provide formulation development, stability studies, and clinical information on new/existing formulations. The PICs are also essential in pharmacist oversight of QuVa operations. Additionally, Travis has been instrumental in creating multiple formulation patents for QuVa.

Throughout his storied career in the compounding/outsourcing industry, Travis has served in various roles such as Owner, CEO, President, COO, and VP. Travis led Unique Pharmaceuticals through full remediation and transformation into compliance with the FDA 503B cGMP standards, achieving third-party sterility assurance certification on the facility. He has served on two Texas State Board of Pharmacy Compounding Committees and has been instrumental in advocating for rules and quality-based regulations within the compounding industry. He has also served eight years on the Board of Directors for the Central Texas Children’s Center, a non-profit organization that provides educational, habilitative, and social programs for children with special needs.

Travis earned his Bachelor of Science in Pharmacy from the University of Texas at Austin and his MBA from Baylor University.

Having more than 26 years in the manufacturing business and 20 years in the pharmaceutical industry, Bob possesses a diverse background in both technical management and operational leadership in pharmaceutical manufacturing. His career experience includes maintenance & engineering, reliability, aseptic manufacturing, and biologics manufacturing. Bob joined QuVa’s leadership team in August 2021 as Vice President, Manufacturing Operations. Before joining QuVa Pharma, he held various leadership roles with Pharmacia, Pfizer, and Sanofi, across multiple business units. Throughout Bob’s extensive career, he developed deep experience in team building, employee development, and change management towards continuous improvement and operational excellence. Bob earned his Bachelor of Science in Mechanical Engineering from Yale University and his MBA from Western Michigan University.

With a diverse career spanning five continents, Mike has nearly 45 years of experience in business leadership and diverse technical management in the pharmaceutical industry. At QuVa, Mike’s current roll is focused on increasing all employees’ awareness and adherence to cGMP requirements across all aspects of the business.  Previously he led QuVa’s integration of automated solutions while optimizing compounding processes in support of sterile manufacturing and supply chain platforms. Mike and his team continually focus on knowledge transfer and process design to optimize, automate, and advance QuVa’s performance levels and output.  His in-depth knowledge of Good Manufacturing Practices and regulatory requirements ensures sustainable, compliant solutions to prevent drug shortages.  The establishment of a GMP Compliance Office is yet another sign of QuVa’s growth, maturity, and recognition of what it takes to be the top service provider in the 503B Industry.

Having nearly 20 years of pharmaceutical experience, Travis is knowledgeable in cGMP’s and specializes in parenteral drug manufacturing, specifically within Quality and Manufacturing Operations. Prior to QuVa Pharma, Travis held leadership roles in both Quality and Manufacturing, with Par, JHP Pharmaceuticals supporting the manufacture of sterile and aseptically produced products. And most recently, Travis supported a rapidly growing Cell & Gene Therapy site, for Lonza, delivering a zero 483, pre-approval inspection, for two critical products. Travis has a passion for developing and creating high performing teams, across multiple business units, and delivering on the need for continuous improvement.

As a member of QuVa’s leadership team since inception, Donna Kohut, Vice President of Strategic Projects, applies her 30+ years of experience in pharmaceutical manufacturing to drive key business objectives and implement strategies for continued growth and operational effectiveness. Her storied career has included various positions in Supply Chain, Manufacturing, Quality, and Compliance in organizations both domestic and international, such as Johnson & Johnson, Mayne Pharmaceutical, and independent consulting to drug, medical devices, chemical, and allied heath businesses. Donna’s passion for exceptional service to customers, employees, and the community exemplifies QuVa’s core values and mission.

Ray Milnes joins QuVa with more than 20 years of combined experience in the healthcare industry leading commercial organizations for Covidien, Medtronic, Cardinal Health, and Scrip Companies.  His experiences span the care continuum building commercial excellence across medical devices, medical supplies, distribution services, new product launches, business development, and corporate strategy.   

Ray is leading QuVa’s National Field Sales, Customer Service, Sales Operation, and Customer Onboarding and Integration.

Puneet Jain holds a master’s degree in Electrical Engineering from the University of Southern California and brings a wealth of knowledge to QuVa Pharma.

He is experienced in project and portfolio management, product commercialization, large capital projects, engineering and maintenance, strategy and long-range planning, industrial automation, and operational excellence.

At QuVa, he is responsible for corporate facilities management with direct involvement across the company’s manufacturing platform regarding facility capital projects and strategic planning initiatives, facilities design, compliance, technology continuous improvement and innovation.

Puneet lives in Bethlehem, PA and will be supporting all QuVa facilities while leading the Engineering and Maintenance team.

Shannon brings a wealth of experience to the organization as the former Global Chief Human Resources Officer for the Institute of Electrical and Electronics Engineers (IEEE). Most recently, she led the formation of the HR function for two high-growth generic pharmaceutical companies. In addition to her extensive on-the-ground experience, Shannon holds a BA in Psychology, an MS in Organizational Leadership, and the Senior Professional in Human Resources (SPHR) certification.

With over 26 years of experience in information technology spanning multiple industries, Jaise has led numerous large IT Projects focusing on Digital Transformation, IT operations, and project management toward technology advancement. Jaise is responsible for leading QuVa’s current transformation journey involving several re-implementations of crucial systems and processes, including our ERP, while directing and controlling the development, implementation, and maintenance of the company's information system applications and strategies.